NEW YORK (GenomeWeb News) — DNAVision today said it has purchased Bioreg, a pharmacogenetics contract lab.
 
Brussels, Belgium-based DNAVision offers SNP genotyping and sequencing services to European customers. It said the acquisition brings together two labs that are experienced with “genotyping volunteers and patients in clinical trials.”
 
Financial terms of the deal were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.